|
March 2022 
ALPHEUS MEDICAL FORMS WORLD-CLASS SCIENTIFIC ADVISORY BOARD (SAB) CO-LED BY ROGER STUPP, MD TO SUPPORT DEVELOPMENT OF NOVEL TREATMENT FOR BRAIN CANCERRoger Stupp, MD, is one of four individuals appointed to the new world-class Scientific Advisory Board (SAB). Alpheus Medical CEO, Vijay Agarwal, MD, describes the board as being comprised of "the world's foremost thought leaders in glioblastoma."
The goal of the board is to provide meaningful guidance as the company begins a first-in-human clinical trial of their proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas. "I am excited to lead this team of exceptional clinicians and researchers as we begin enrollment in the first-in-human trial over the coming months," said Dr. Stupp. "Alpheus' approach is very promising and has the potential to radically change how we treat patients with recurrent glioblastoma." Learn more > |
Roger Stupp, MD, is the Paul C. Bucy Professor of Neurological Surgery, Professor of Neurology and Medicine (Hematology/Oncology), chief of Neuro-Oncology, and co-director of the Lou and Jean Malnati Brain Tumor Institute at Northwestern Medicine.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
You May Also Like
|
|
|